$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Friday, there were a few notable insider trades.
儘管美國股市週五收盤走低，但仍有一些值得注意的內幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
當內部人士購買股票時，這表明他們對公司的前景充滿信心，或者他們認為這只股票很划算。無論哪種方式，這都標誌著做多該股的機會。內幕收購不應被視為做出投資或交易決定的唯一指標。充其量，它可以讓買入決定更有說服力。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近幾筆值得注意的內幕交易。欲瞭解更多資訊，請查看Benzinga的內幕交易站臺。
Day One Biopharmaceuticals
生物製藥的第一天
- The Trade: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) 10% owner Len Blavatnik acquired a total of 1,475,454 shares an average price of $10.15. To acquire these shares, it cost around $14.98 million.
- What's Happening: Day One Biopharmaceuticals submitted rolling new drug application to the FDA for tovorafenib in relapsed or progressive pediatric low-grade glioma.
- What Day One Biopharmaceuticals Does: Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers.
- 行業： 第一天生物製藥公司。(納斯達克：黎明)10%的所有者Len Blavatnik共購入1,475,454股均價為10.15美元。收購這些股份的成本約為1498萬美元。
- 正在發生的事情：第一天，生物製藥公司向FDA提交了針對託伏拉非尼治療復發或進展性兒童低級別膠質瘤的滾動新藥申請。
- 第一天生物製藥的用途：第一天生物製藥公司是一家臨床階段的生物製藥公司。它致力於為所有年齡段的基因定義癌症患者開發和商業化靶向治療。
Central Securities
中央證券
- The Trade: Central Securities Corporation (NYSE:CET) Vice President Andrew J. O'Neill acquired a total of 1,954 shares at an average price of $35.80. To acquire these shares, it cost around $69,947.
- What's Happening: The company's stock gained around 6% year-to-date.
- What Central Securities Does: Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital.
- 行業： 中央證券公司(紐約證券交易所股票代碼：CET)副總裁安德魯·J·奧尼爾以35.8美元的平均價格收購了1,954股。收購這些股票的成本約為69,947美元。
- 正在發生的事情：今年到目前為止，該公司的股票上漲了約6%。
- 中央證券的業務：中央證券公司是一家非多元化封閉式管理投資公司。其投資目標是資本的長期增長。
Don't forget to check out our premarket coverage here
別忘了在這裡查看我們的售前報道
RE/MAX Holdings
Re/Max Holdings
- The Trade: RE/MAX Holdings, Inc. (NYSE:RMAX) 10% owner Magnolia Group LLC bought a total of 15,000 shares at an average price of $10.74. To acquire these shares, it cost around $161,100.
- What's Happening: RE/MAX Hldgs posted in-line earnings for the second quarter.
- What RE/MAX Holdings Does: RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises.
- 行業： Re/Max控股公司(紐約證券交易所代碼：RMAX)10%的股東木蘭花集團有限責任公司共買入15,000股均價為10.74美元。收購這些股票的成本約為161,100美元。
- 正在發生的事情：Re/Max Hldgs公佈了第二季度的在線收益。
- RE/MAX控股公司的業務：Re/Max Holdings Inc.是房地產經紀服務的特許經營商。它招募和保留代理商，並銷售特許經營權。
Check This Out: Top 4 Health Care Stocks That May Rocket Higher This Month
看看這個：4大醫療保健類股本月可能走高